Pharmacology of GORD Flashcards
give 3 NSAIDs
ibuprofen, naproxen, diclonefac
describe the primary mechanism of action for NSAIDs
inhibits cyclo-oxygenase, this is the rate limiting step for production of all prostanoids from arachidonic acid, thought that most wanted effects come from inhibition of COX2 whilst unwanted effects are from COX1 inhibition
prostanoids includes
prostaglandins and thromboxanes
what is the drug target for NSAIDs
cyclo oxygenase enzyme
what are common unwanted effects of NSAIDs
gastric irritation, ulceration and in extreme cases perforation, also reduced creatinine and possible nephritis, bronchoconstriction in susceptible individuals, skin rashes, other allergies, dizziness, tinnitus
in which patients is NSAIDs constricted for and why
asthma bc of the bronchoconstrictive effects
what are the adverse cardiovascular effects of NSAIDs
hypertension, stroke, MI may occur following prolonged use or in patients with pre-existing CV risk
prolonged analgesic abuse of NSAIDs over years is associated with what
chronic renal failure
what has aspirin use been linked with
a rare but serious post viral encephalitis (Reye’s syndrome) in children
what are the main uses for NSAIDs
analgesics (musculoskeletal pain, headache, dysmenorrhoea), antipyretics, anti inflammatories for chronic control of inflammatory disease
what else is aspirin used for
anti aggregatory agent to inhibit platelet aggregation in patient at risk of stroke or MI
what chronic inflammatory diseases are NSAIDs used to control
rheumatoid arthritis, OA)
give 2 Proton pump inhibitors
omeprazole, lansoprazole
what is the primary mechanism of action of PPIs
irreversible inhibitors of H+/K+ ATPase in gastric parietal cells, they are weak bases so accumulate in acid environment of canaliculi or parietal cells which concentrates action and prolongs it too
by how much is omeprasole’s action prolonged by
its plasma half life is 1h but single daily dose affects acid secretion for 2-3 days
by how much do PPIs inhibit basal and stimulated gastric acid secretion
by over 90%
what is the drug target for PPIs
H+/K+ ATPase (proton pump)
what are side effects of PPIs
headache, diarrhoea, bloating, abdominal pain, rashes
can also mask gastric cancer symptoms
what else does omeprazole do
inhibits cytochrome P2C19 and has been reported to reduce activity of eg clopidogrel when monitoring platelet function
are PPIs pro drugs if so how are they metabolised
yes, at low pH converted into 2 reactive species which react with the sulphydryl groups in H+/K+ ATPase
how are PPIs administered
orally but bc the degrade rapidly at low pH they are in capsules containing enteric coated granules
what is ranitidine
H2 histamine receptor antagonist
what is the primary mechanism of action of ranitidine
competitive antagonist of H2 receptors, so inhibit stimulatory action of histamine released from enterochromaffin like (ECL) cells on gastric parietal cells
by how much do H2 receptor antagonists reduce gastric secretion
approx 60%